Fang, Cheng
Liang, Haixi
Shen, Xiujiao
Li, Jing
Liang, Chuqiao
Zhu, Dongqin
Yang, Lingling
Wang, Xuehan
Zheng, Min
Zheng, Ruinian
Wu, Miaofang
Huang, Xin
Lan, Chunyan
Funding for this research was provided by:
National 2030 Projects of Scientific and Technological innovation (2023ZD0500304)
National Natural Science Foundation of China (82573022)
Article History
Received: 7 March 2026
Accepted: 31 July 2026
First Online: 17 August 2026
Declarations
Ethics approval and consent to participate: The study was approved by the Sun Yat-sen University Cancer Center Ethics Committee (Reference Number, B2022-348-X01) and the ethics committee at each participating site. All patients provided written informed consent prior to enrollment.
Consent for publication: Not applicable. All data presented in this study are anonymized and do not contain identifiable information.
Competing interests: Chuqiao Liang, Dongqin Zhu, and Lingling Yang are employees of Nanjing Geneseeq Technology Inc. All other authors declare no competing interests.